NGM
NGM Biopharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
David J. Woodhouse
IPO Date
2019-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
NGM Biopharmaceuticals, Inc.
CEO
David J. Woodhouse
IPO Date
2019-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 24,222 |
| $13.35 |
| 8 Apr 2024 | Guyer Shelly D | director | D-Return | Disposed | 49,197 | $17.24 |
| 8 Apr 2024 | Guyer Shelly D | director | D-Return | Disposed | 16,806 | $20.37 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | D-Return | Disposed | 78,407 | $3.69 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | U-Tender | Disposed | 7,000 | $1.55 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | D-Return | Disposed | 24,000 | $13.35 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | D-Return | Disposed | 19,619 | $17.24 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | D-Return | Disposed | 16,806 | $20.37 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | D-Return | Disposed | 25,000 | $12.06 |